Loading...

URGN UROGEN PHARMA LTD Earnings Reports 8-K Filing

RGN

RGN

UROGEN PHARMA LTD

(URGN)

2025 8-K

Show Summary

Show Summary

New Product Launches

Financial Statements

Financial Results

Asset Acquisition

Investor Presentation

Financial Results

Director Resignation

Financial Results

Annual Meeting Approval

Public Offering

Positive Data from Phase 3 ...

Financial Results Announcement

Financial Results Announcement

Presentation at Conference

Notice of ANDA Submission

Agreement and Phase 3 Study

Amendment to Manufacturing ...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Private Placement

Financial Results Announcement

External Links:

On May 12, 2025, UroGen Pharma Ltd. reported its financial results for the quarter ending March 31, 2025. The details are provided in an attached press release (Exhibit 99.1).

AI Assistant

UROGEN PHARMA LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.